chr19-3633461-C-CG
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PVS1_ModeratePM2
The NM_012398.3(PIP5K1C):c.1979_1980insC(p.Ala661GlyfsTer81) variant causes a frameshift change. The variant allele was found at a frequency of 0.000351 in 1,501,830 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00030 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00036 ( 0 hom. )
Consequence
PIP5K1C
NM_012398.3 frameshift
NM_012398.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.39
Genes affected
PIP5K1C (HGNC:8996): (phosphatidylinositol-4-phosphate 5-kinase type 1 gamma) This locus encodes a type I phosphatidylinositol 4-phosphate 5-kinase. The encoded protein catalyzes phosphorylation of phosphatidylinositol 4-phosphate, producing phosphatidylinositol 4,5-bisphosphate. This enzyme is found at synapses and has been found to play roles in endocytosis and cell migration. Mutations at this locus have been associated with lethal congenital contractural syndrome. Alternatively spliced transcript variants encoding different isoforms have been described.[provided by RefSeq, Sep 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.014 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIP5K1C | NM_012398.3 | c.1979_1980insC | p.Ala661GlyfsTer81 | frameshift_variant | 17/18 | ENST00000335312.8 | NP_036530.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PIP5K1C | ENST00000335312.8 | c.1979_1980insC | p.Ala661GlyfsTer81 | frameshift_variant | 17/18 | 1 | NM_012398.3 | ENSP00000335333 | P3 | |
PIP5K1C | ENST00000679885.1 | c.2057_2058insC | p.Ala687GlyfsTer81 | frameshift_variant | 18/19 | ENSP00000504894 | A1 | |||
PIP5K1C | ENST00000539785.5 | c.1921-293_1921-292insC | intron_variant | 2 | ENSP00000445992 | A1 | ||||
PIP5K1C | ENST00000679828.1 | c.*1518_*1519insC | 3_prime_UTR_variant, NMD_transcript_variant | 18/19 | ENSP00000506175 |
Frequencies
GnomAD3 genomes AF: 0.000302 AC: 46AN: 152084Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
46
AN:
152084
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000357 AC: 482AN: 1349628Hom.: 0 Cov.: 31 AF XY: 0.000343 AC XY: 227AN XY: 661000
GnomAD4 exome
AF:
AC:
482
AN:
1349628
Hom.:
Cov.:
31
AF XY:
AC XY:
227
AN XY:
661000
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000296 AC: 45AN: 152202Hom.: 1 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74418
GnomAD4 genome
AF:
AC:
45
AN:
152202
Hom.:
Cov.:
33
AF XY:
AC XY:
13
AN XY:
74418
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 23, 2023 | Frameshift variant predicted to result in protein truncation as the last 8 amino acids are replaced with 80 different amino acids, although loss-of-function variants have not been reported downstream of this position in the protein; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at